CIBC Private Wealth Group
BIOR

CIBC Private Wealth Group’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

CIBC Private Wealth Group’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-40
Closed -$5K – 965
2022
Q3 		$5K Hold
40
– – ﹤0.01% 906
2022
Q2 		$7K Hold
40
– – ﹤0.01% 1092
2022
Q1 		$12K Hold
40
– – ﹤0.01% 1128
2021
Q4 		$21K Hold
40
– – ﹤0.01% 1008
2021
Q3 		$15K Buy
+40
New +$17.2K ﹤0.01% 927

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
WA
WealthTrust Axiom Wayne, Pennsylvania $406M AUM 40.44% 1-Year Est. Return

CIBC Private Wealth Group's BIOR Position: Q4 2022 in Review

CIBC Private Wealth Group sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q4 2022, closing a stake of 40 shares — an estimated $5K sold.

CIBC Private Wealth Group first reported a position in BIOR in Q3 2021 and held it in 5 quarters. The position peaked at $21K in Q4 2021. 42 funds tracked by Wall St. Rank hold BIOR as of Q4 2022.

  • CIBC Private Wealth Group reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • CIBC Private Wealth Group sold 40 Biora Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $5K.
  • CIBC Private Wealth Group first reported a position in Biora Therapeutics, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
  • CIBC Private Wealth Group's Biora Therapeutics, Inc. Common Stock position peaked at $21K in Q4 2021.
  • 42 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q4 2022.

Based on CIBC Private Wealth Group's 13F filing for Q4 2022, filed 13 Feb 2023.